Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Andrea C. King

TitlePROFESSOR
InstitutionUniversity of Chicago
DepartmentPsychiatry & Behav. Neurosci
AddressChicago IL 60637
Email
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Clinical Interests
    Assessment and treatment of substance use disorders
    Tobacco and alcohol addictions in medical and psychiatric patients.
    Cancer prevention and control.

    Research Interests
    Identifying risk factors, biological vulnerability, and co-morbidities in substance use disorders.
    Examining efficacy of behavioral and pharmacological treatments for nicotine, alcohol, and other addictive disorders.
    Targeting treatments for minority and underserved smokers.


    Collapse Biography 
    Collapse education and training
    University of Oklahoma Health Sciences CenterPh.D. 1992
    University of Pennsylvania1994Post-doctoral Fellowship
    New York Medical College, St. Vincent’s HospitalInternship1995
    Illinois Licensed Clinical Psychologist

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Fridberg DJ, Faria J, Cao D, King AC. Real-Time Mobile Monitoring of Drinking Episodes in Young Adult Heavy Drinkers: Development and Comparative Survey Study. JMIR Mhealth Uhealth. 2019 Nov 20; 7(11):e13765. PMID: 31746774.
      View in: PubMed
    2. Matthews AK, Steffen AD, Kuhns LM, Ruiz RA, Ross NA, Burke LA, Li CC, King AC. Evaluation of a Randomized Clinical Trial Comparing the Effectiveness of a Culturally Targeted and Nontargeted Smoking Cessation Intervention for Lesbian, Gay, Bisexual, and Transgender Smokers. Nicotine Tob Res. 2019 Oct 26; 21(11):1506-1516. PMID: 30169797.
      View in: PubMed
    3. Berey BL, Leeman RF, Chavarria J, King AC. Relationships between generalized impulsivity and subjective stimulant and sedative responses following alcohol administration. Psychol Addict Behav. 2019 Nov; 33(7):616-625. PMID: 31497988.
      View in: PubMed
    4. King AC, Cao D, deWit H, O'Connor SJ, Hasin DS. The role of alcohol response phenotypes in the risk for alcohol use disorder. BJPsych Open. 2019 Apr 22; 5(3):e38. PMID: 31685074.
      View in: PubMed
    5. Chavarria J, Liu M, Kast L, Salem E, King AC. A pilot study of Counsel to Quit®: Evaluating an Ask Advise Refer (AAR)-based tobacco cessation training for medical and mental healthcare providers. J Subst Abuse Treat. 2019 Apr; 99:163-170. PMID: 30797390.
      View in: PubMed
    6. Grant JE, Lust K, Fridberg DJ, King AC, Chamberlain SR. E-cigarette use (vaping) is associated with illicit drug use, mental health problems, and impulsivity in university students. Ann Clin Psychiatry. 2019 02; 31(1):27-35. PMID: 30699215.
      View in: PubMed
    7. Roche DJO, Trela CJ, Argos M, Jasmine F, Kibriya MG, Ahsan H, King AC. Lack of Association between Opioid-Receptor Genotypes and Smoking Cessation Outcomes in a Randomized, Controlled Naltrexone Trial. Alcohol Alcohol. 2019 Jan 09; 54(5):559-565. PMID: 31206155.
      View in: PubMed
    8. Schacht JP, Anton RF, McNamara PJ, Im Y, King AC. The dopamine transporter VNTR polymorphism moderates the relationship between acute response to alcohol and future alcohol use disorder symptoms. Addict Biol. 2019 Sep; 24(5):1109-1118. PMID: 30230123.
      View in: PubMed
    9. Chavarria J, Rueger SY, King AC. Hangover in Post-College-Aged Drinkers: Psychometric Properties of the Hangover Symptom Scale (HSS) and the Hangover Symptom Scale-Short Form (HSS-5). Alcohol Clin Exp Res. 2018 06; 42(6):1122-1131. PMID: 29660151.
      View in: PubMed
    10. King AC, Smith LJ, McNamara PJ, Cao D. Second Generation Electronic Nicotine Delivery System Vape Pen Exposure Generalizes as a Smoking Cue. Nicotine Tob Res. 2018 01 05; 20(2):246-252. PMID: 28082323.
      View in: PubMed
    11. Fridberg DJ, Rueger SY, Smith P, King AC. Association of Anticipated and Laboratory-Derived Alcohol Stimulation, Sedation, and Reward. Alcohol Clin Exp Res. 2017 Jul; 41(7):1361-1369. PMID: 28493556.
      View in: PubMed
    12. Smith LJ, McNamara PJ, King AC. Optimizing follow-up and study retention in the 21st century: Advances from the front line in alcohol and tobacco research. Drug Alcohol Depend. 2017 06 01; 175:171-178. PMID: 28437721.
      View in: PubMed
    13. Miller MA, Bershad A, King AC, Lee R, de Wit H. Intranasal oxytocin dampens cue-elicited cigarette craving in daily smokers: a pilot study. Behav Pharmacol. 2016 12; 27(8):697-703. PMID: 27661192.
      View in: PubMed
    14. Coccaro EF, Keedy SK, Gorka SM, King AC, Fanning JR, Lee RJ, Phan KL. Differential fMRI BOLD responses in amygdala in intermittent explosive disorder as a function of past Alcohol Use Disorder. Psychiatry Res Neuroimaging. 2016 Nov 30; 257:5-10. PMID: 27693977.
      View in: PubMed
    15. Coccaro EF, Fridberg DJ, Fanning JR, Grant JE, King AC, Lee R. Substance use disorders: Relationship with intermittent explosive disorder and with aggression, anger, and impulsivity. J Psychiatr Res. 2016 10; 81:127-32. PMID: 27442963.
      View in: PubMed
    16. Cao D, Zhuang X, Kang P, Hong SW, King AC. Acute Alcohol Drinking Promotes Piecemeal Percepts during Binocular Rivalry. Front Psychol. 2016; 7:489. PMID: 27092096.
      View in: PubMed
    17. Roche DJ, Ray LA, Yardley MM, King AC. Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokers. Curr Addict Rep. 2016 Mar; 3(1):125-137. PMID: 27162709.
      View in: PubMed
    18. King AC, Smith LJ, Fridberg DJ, Matthews AK, McNamara PJ, Cao D. Exposure to electronic nicotine delivery systems (ENDS) visual imagery increases smoking urge and desire. Psychol Addict Behav. 2016 Feb; 30(1):106-12. PMID: 26618797.
      View in: PubMed
    19. Hu HX, Zang GB, Liu ZL, Rueger SY, McNamara P, King AC, Hao W. Different Subjective and Objective Responses to Alcohol Among Heavy and Light Drinkers of Han and Uyghur Nationalities in China. J Addict Nurs. 2015 Oct-Dec; 26(4):191-202. PMID: 26669226.
      View in: PubMed
    20. Fridberg DJ, Cao D, King AC. Integrating alcohol response feedback in a brief intervention for young adult heavy drinkers who smoke: A pilot study. Drug Alcohol Depend. 2015 Oct 01; 155:293-7. PMID: 26341847.
      View in: PubMed
    21. Bress A, Kittles R, Wing C, Hooker SE, King A. Genetic ancestry as an effect modifier of naltrexone in smoking cessation among African Americans: an analysis of a randomized controlled trial. Pharmacogenet Genomics. 2015 Jun; 25(6):305-12. PMID: 25918964.
      View in: PubMed
    22. King AC, Hasin D, O'Connor SJ, McNamara PJ, Cao D. A Prospective 5-Year Re-examination of Alcohol Response in Heavy Drinkers Progressing in Alcohol Use Disorder. Biol Psychiatry. 2016 Mar 15; 79(6):489-98. PMID: 26117308.
      View in: PubMed
    23. Roche DJ, King AC. Sex differences in acute hormonal and subjective response to naltrexone: The impact of menstrual cycle phase. Psychoneuroendocrinology. 2015 Feb; 52:59-71. PMID: 25459893.
      View in: PubMed
    24. Fridberg DJ, Cao D, Grant JE, King AC. Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking. Alcohol Clin Exp Res. 2014 Oct; 38(10):2622-9. PMID: 25335648.
      View in: PubMed
    25. Rueger SY, Hu H, McNamara P, Cao D, Hao W, King AC. Differences in subjective response to alcohol in heavy- and light-drinking Chinese men versus Caucasian American men. Addiction. 2015 Jan; 110(1):91-9. PMID: 25203488.
      View in: PubMed
    26. Asvat Y, Cao D, Africk JJ, Matthews A, King A. Feasibility and effectiveness of a community-based smoking cessation intervention in a racially diverse, urban smoker cohort. Am J Public Health. 2014 Sep; 104 Suppl 4:S620-7. PMID: 25100429.
      View in: PubMed
    27. Fucito LM, Toll BA, Roos CR, King AC. Smokers' Treatment Expectancies Predict Smoking Cessation Success. J Smok Cessat. 2016 Sep; 11(3):143-149. PMID: 27594921.
      View in: PubMed
    28. King AC, Smith LJ, McNamara PJ, Matthews AK, Fridberg DJ. Passive exposure to electronic cigarette (e-cigarette) use increases desire for combustible and e-cigarettes in young adult smokers. Tob Control. 2015 Sep; 24(5):501-4. PMID: 24848637.
      View in: PubMed
    29. Roche DJ, Palmeri MD, King AC. Acute alcohol response phenotype in heavy social drinkers is robust and reproducible. Alcohol Clin Exp Res. 2014 Mar; 38(3):844-52. PMID: 24117681.
      View in: PubMed
    30. King AC, McNamara PJ, Hasin DS, Cao D. Alcohol challenge responses predict future alcohol use disorder symptoms: a 6-year prospective study. Biol Psychiatry. 2014 May 15; 75(10):798-806. PMID: 24094754.
      View in: PubMed
    31. King A, Cao D, Zhang L, Rueger SY. Effects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trial. Addiction. 2013 Oct; 108(10):1836-44. PMID: 23714324.
      View in: PubMed
    32. Roche DJ, King AC, Cohoon AJ, Lovallo WR. Hormonal contraceptive use diminishes salivary cortisol response to psychosocial stress and naltrexone in healthy women. Pharmacol Biochem Behav. 2013 Aug; 109:84-90. PMID: 23672966.
      View in: PubMed
    33. Gorka SM, Fitzgerald DA, King AC, Phan KL. Alcohol attenuates amygdala-frontal connectivity during processing social signals in heavy social drinkers: a preliminary pharmaco-fMRI study. Psychopharmacology (Berl). 2013 Sep; 229(1):141-54. PMID: 23584670.
      View in: PubMed
    34. Sivasithamparam J, Visk CA, Cohen EE, King AC. Modifiable risk behaviors in patients with head and neck cancer. Cancer. 2013 Jul 01; 119(13):2419-26. PMID: 23575663.
      View in: PubMed
    35. Matthews AK, Conrad M, Kuhns L, Vargas M, King AC. Project Exhale: preliminary evaluation of a tailored smoking cessation treatment for HIV-positive African American smokers. AIDS Patient Care STDS. 2013 Jan; 27(1):22-32. PMID: 23305259.
      View in: PubMed
    36. Morean ME, de Wit H, King AC, Sofuoglu M, Rueger SY, O'Malley SS. The drug effects questionnaire: psychometric support across three drug types. Psychopharmacology (Berl). 2013 May; 227(1):177-92. PMID: 23271193.
      View in: PubMed
    37. King AC, Cao D, Zhang L, O'Malley SS. Naltrexone reduction of long-term smoking cessation weight gain in women but not men: a randomized controlled trial. Biol Psychiatry. 2013 May 01; 73(9):924-30. PMID: 23177384.
      View in: PubMed
    38. Rueger SY, King AC. Validation of the brief Biphasic Alcohol Effects Scale (B-BAES). Alcohol Clin Exp Res. 2013 Mar; 37(3):470-6. PMID: 23078583.
      View in: PubMed
    39. King AC, Cao D, O'Malley SS, Kranzler HR, Cai X, deWit H, Matthews AK, Stachoviak RJ. Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women. J Clin Psychopharmacol. 2012 Oct; 32(5):630-6. PMID: 22926596.
      View in: PubMed
    40. Rueger SY, Trela CJ, Palmeri M, King AC. Self-administered web-based timeline followback procedure for drinking and smoking behaviors in young adults. J Stud Alcohol Drugs. 2012 Sep; 73(5):829-33. PMID: 22846247.
      View in: PubMed
    41. Lovallo WR, King AC, Farag NH, Sorocco KH, Cohoon AJ, Vincent AS. Naltrexone effects on cortisol secretion in women and men in relation to a family history of alcoholism: studies from the Oklahoma Family Health Patterns Project. Psychoneuroendocrinology. 2012 Dec; 37(12):1922-8. PMID: 22575355.
      View in: PubMed
    42. Childs E, Roche DJ, King AC, de Wit H. Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements. Alcohol Clin Exp Res. 2012 May; 36(5):906-14. PMID: 22339626.
      View in: PubMed
    43. Plebani JG, Ray LA, Morean ME, Corbin WR, MacKillop J, Amlung M, King AC. Human laboratory paradigms in alcohol research. Alcohol Clin Exp Res. 2012 Jun; 36(6):972-83. PMID: 22309888.
      View in: PubMed
    44. King AC, Roche DJ, Rueger SY. Subjective responses to alcohol: a paradigm shift may be brewing. Alcohol Clin Exp Res. 2011 Oct; 35(10):1726-8. PMID: 21919923.
      View in: PubMed
    45. King AC, de Wit H, McNamara PJ, Cao D. Rewarding, stimulant, and sedative alcohol responses and relationship to future binge drinking. Arch Gen Psychiatry. 2011 Apr; 68(4):389-99. PMID: 21464363.
      View in: PubMed
    46. King AC, Cao D, Southard CC, Matthews A. Racial differences in eligibility and enrollment in a smoking cessation clinical trial. Health Psychol. 2011 Jan; 30(1):40-8. PMID: 21299293.
      View in: PubMed
    47. Sripada CS, Angstadt M, McNamara P, King AC, Phan KL. Effects of alcohol on brain responses to social signals of threat in humans. Neuroimage. 2011 Mar 01; 55(1):371-80. PMID: 21122818.
      View in: PubMed
    48. Sánchez-Johnsen LA, Carpentier MR, King AC. Race and sex associations to weight concerns among urban African American and Caucasian smokers. Addict Behav. 2011 Jan-Feb; 36(1-2):14-7. PMID: 20832176.
      View in: PubMed
    49. Roche DJ, King AC. Alcohol impairment of saccadic and smooth pursuit eye movements: impact of risk factors for alcohol dependence. Psychopharmacology (Berl). 2010 Sep; 212(1):33-44. PMID: 20635179.
      View in: PubMed
    50. Hamidovic A, Childs E, Conrad M, King A, de Wit H. Stress-induced changes in mood and cortisol release predict mood effects of amphetamine. Drug Alcohol Depend. 2010 Jun 01; 109(1-3):175-80. PMID: 20176450.
      View in: PubMed
    51. Shah LM, King AC, Basu A, Krishnan JA, Borden WB, Meltzer D, Arora V. Effect of clinician advice and patient preparedness to quit on subsequent quit attempts in hospitalized smokers. J Hosp Med. 2010 Jan; 5(1):26-32. PMID: 20063403.
      View in: PubMed
    52. King A, McNamara P, Angstadt M, Phan KL. Neural substrates of alcohol-induced smoking urge in heavy drinking nondaily smokers. Neuropsychopharmacology. 2010 Feb; 35(3):692-701. PMID: 19907419.
      View in: PubMed
    53. King A, McNamara P, Conrad M, Cao D. Alcohol-induced increases in smoking behavior for nicotinized and denicotinized cigarettes in men and women. Psychopharmacology (Berl). 2009 Nov; 207(1):107-17. PMID: 19756530.
      View in: PubMed
    54. Roche DJ, Childs E, Epstein AM, King AC. Acute HPA axis response to naltrexone differs in female vs. male smokers. Psychoneuroendocrinology. 2010 May; 35(4):596-606. PMID: 19837518.
      View in: PubMed
    55. King A, Cao D, Vanier C, Wilcox T. Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study. Alcohol Clin Exp Res. 2009 Jun; 33(6):1044-50. PMID: 19302083.
      View in: PubMed
    56. Rueger SY, McNamara PJ, King AC. Expanding the utility of the Biphasic Alcohol Effects Scale (BAES) and initial psychometric support for the Brief-BAES (B-BAES). Alcohol Clin Exp Res. 2009 May; 33(5):916-24. PMID: 19320625.
      View in: PubMed
    57. King A, Epstein A, Conrad M, McNamara P, Cao D. Sex differences in the relationship between alcohol-associated smoking urge and behavior: a pilot study. Am J Addict. 2008 Sep-Oct; 17(5):347-53. PMID: 18770076.
      View in: PubMed
    58. King A, Sánchez-Johnsen L, Van Orman S, Cao D, Matthews A. A pilot community-based intensive smoking cessation intervention in African Americans: feasibility, acceptability and early outcome indicators. J Natl Med Assoc. 2008 Feb; 100(2):208-17. PMID: 18300538.
      View in: PubMed
    59. Brumback T, Cao D, King A. Effects of alcohol on psychomotor performance and perceived impairment in heavy binge social drinkers. Drug Alcohol Depend. 2007 Nov 02; 91(1):10-7. PMID: 17560739.
      View in: PubMed
    60. Tuvlin JA, Raza SS, Bracamonte S, Julian C, Hanauer SB, Nicolae DL, King AC, Cho JH. Smoking and inflammatory bowel disease: trends in familial and sporadic cohorts. Inflamm Bowel Dis. 2007 May; 13(5):573-9. PMID: 17345609.
      View in: PubMed
    61. King A, de Wit H, Riley RC, Cao D, Niaura R, Hatsukami D. Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences. Nicotine Tob Res. 2006 Oct; 8(5):671-82. PMID: 17008194.
      View in: PubMed
    62. Epstein AM, Sher TG, Young MA, King AC. Tobacco chippers show robust increases in smoking urge after alcohol consumption. Psychopharmacology (Berl). 2007 Feb; 190(3):321-9. PMID: 16804691.
      View in: PubMed
    63. King A, Munisamy G, de Wit H, Lin S. Attenuated cortisol response to alcohol in heavy social drinkers. Int J Psychophysiol. 2006 Mar; 59(3):203-9. PMID: 16359745.
      View in: PubMed
    64. King AC, Epstein AM. Alcohol dose-dependent increases in smoking urge in light smokers. Alcohol Clin Exp Res. 2005 Apr; 29(4):547-52. PMID: 15834219.
      View in: PubMed
    65. King AC, Canada SA. Client-related predictors of early treatment drop-out in a substance abuse clinic exclusively employing individual therapy. J Subst Abuse Treat. 2004 Apr; 26(3):189-95. PMID: 15063912.
      View in: PubMed
    66. Epstein AM, King AC. Naltrexone attenuates acute cigarette smoking behavior. Pharmacol Biochem Behav. 2004 Jan; 77(1):29-37. PMID: 14724039.
      View in: PubMed
    67. King AC, Byars JA. Alcohol-induced performance impairment in heavy episodic and light social drinkers. J Stud Alcohol. 2004 Jan; 65(1):27-36. PMID: 15000501.
      View in: PubMed
    68. Bernardy NC, King AC, Lovallo WR. Cardiovascular responses to physical and psychological stress in female alcoholics with transitory hypertension after early abstinence. Alcohol Clin Exp Res. 2003 Sep; 27(9):1489-98. PMID: 14506411.
      View in: PubMed
    69. King AC, Bernardy NC, Hauner K. Stressful events, personality, and mood disturbance: gender differences in alcoholics and problem drinkers. Addict Behav. 2003 Jan-Feb; 28(1):171-87. PMID: 12507535.
      View in: PubMed
    70. King AC. Role of naltrexone in initial smoking cessation: preliminary findings. Alcohol Clin Exp Res. 2002 Dec; 26(12):1942-4. PMID: 12500129.
      View in: PubMed
    71. Errico AL, King AC, Lovallo WR, Parsons OA. Cortisol dysregulation and cognitive impairment in abstinent male alcoholics. Alcohol Clin Exp Res. 2002 Aug; 26(8):1198-204. PMID: 12198394.
      View in: PubMed
    72. King AC, Houle T, de Wit H, Holdstock L, Schuster A. Biphasic alcohol response differs in heavy versus light drinkers. Alcohol Clin Exp Res. 2002 Jun; 26(6):827-35. PMID: 12068251.
      View in: PubMed
    73. King AC, Schluger J, Gunduz M, Borg L, Perret G, Ho A, Kreek MJ. Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism. Neuropsychopharmacology. 2002 Jun; 26(6):778-88. PMID: 12007748.
      View in: PubMed
    74. King AC, Meyer PJ. Naltrexone alteration of acute smoking response in nicotine-dependent subjects. Pharmacol Biochem Behav. 2000 Jul; 66(3):563-72. PMID: 10899371.
      View in: PubMed
    75. Holdstock L, King AC, de Wit H. Subjective and objective responses to ethanol in moderate/heavy and light social drinkers. Alcohol Clin Exp Res. 2000 Jun; 24(6):789-94. PMID: 10888066.
      View in: PubMed
    King's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _